Mucosal antibody responses of colonized cattle to Escherichia coli O157-secreted proteins, flagellin, outer membrane proteins and lipopolysaccharide

FEMS Immunology and Medical Microbiology

Volumn 52, Issue 1, 2008, Pages 59-68

  Nart, Pablo ^a,b,c   Holden, Nicola ^b   McAteer, Sean P ^b   Wang, Dai ^b   Flockhart, Allen F ^c   Naylor, Stuart W ^c   Low, J Christopher ^c   Gally, David L ^b   Huntley, John F ^a  

^a MOREDUN RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c SCOTTISH AGRICULTURAL COLLEGE   (United Kingdom)

Author keywords

Escherichia coli O157:H7; Flagellin; Lipopolysaccharide; Mucosal immune responses; OmpC; Secreted proteins

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; FLAGELLIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; OUTER MEMBRANE PROTEIN; PROTEINASE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI O157; EXPERIMENTAL INFECTION; IMMUNOBLOTTING; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; FLAGELLIN; IMMUNITY, MUCOSAL; IMMUNOBLOTTING; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; RECTUM;

EID: 38149140339     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00341.x     Document Type: Article

References (57)

1. Backhed F, Normark S, Schweda EK, Oscarson S Richter-Dahlfors A (2003) Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications. Microbes Infect 5 : 1057 1063.
2. Berin MC, Darfeuille-Michaud A, Egan LJ, Miyamoto Y Kagnoff MF (2002) Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8. Cell Microbiol 4 : 635 648.
3. Beutin L (2006) Emerging enterohaemorrhagic Escherichia coli, causes and effects of the rise of a human pathogen. J Vet Med B Infect Dis Vet Public Health 53 : 299 305.
4. Blasi F, Tarsia P Aliberti S (2005) Strategic targets of essential host-pathogen interactions. Respiration 72 : 9 25.
5. Blattner FR, Plunkett G III., Bloch CA et al 1997) The complete genome sequence of Escherichia coli K-12. Science 277 : 1453 1474.
6. Blomfield IC, Vaughn V, Rest RF Eisenstein BI (1991) Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon. Mol Microbiol 5 : 1447 1457.
7. Caprioli A, Morabito S, Brugere H Oswald E (2005) Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet Res 36 : 289 311.
8. Chart H, Scotland SM, Smith HR Rowe B (1989) Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome. J Clin Pathol 42 : 973 976.
9. Cornelis GR (2006) The type III secretion injectisome. Nat Rev Microbiol 4 : 811 825.
10. Cray WC Jr. Moon HW (1995) Experimental infection of calves and adult cattle with Escherichia coli O157:H7. Appl Environ Microbiol 61 : 1586 1590.
11. Currie CG Poxton IR (1999) The lipopolysaccharide core type of Escherichia coli O157:H7 and other non-O157 verotoxin-producing E. coli. FEMS Immunol Med Microbiol 24 : 57 62.
12. Currie CG, McCallum K Poxton IR (2001) Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease. J Med Microbiol 50 : 345 354.
13. Duck LW, Walter MR, Novak J, Kelly D, Tomasi M, Cong Y Elson CO (2007) Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm Bowel Dis 13 : 1191 1201.
14. Emmerson JR, Gally DL Roe AJ (2006) Generation of gene deletions and gene replacements in Escherichia coli O157:H7 using a temperature sensitive allelic exchange system. Biol Proc Online 8 : 153 162.
15. Fagarasan S Honjo T (2003) Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol 3 : 63 72.
16. Hamburger AE, Bjorkman PJ Herr AB (2006) Structural insights into antibody-mediated mucosal immunity. Curr Top Microbiol Immunol 308 : 173 204.
17. Harper DR, Kit ML Kangro HO (1990) Protein blotting: ten years on. J Virol Methods 30 : 25 39.
18. Hoffman MA, Menge C, Casey TA, Laegreid W, Bosworth BT Dean-Nystrom EA (2006) Bovine immune response to shiga-toxigenic Escherichia coli O157:H7. Clin Vaccine Immunol 13 : 1322 1327.
19. Holden NJ Gally DL (2004) Switches, cross-talk and memory in Escherichia coli adherence. J Med Microbiol 53 : 585 593.
20. Honko AN Mizel SB (2005) Effects of flagellin on innate and adaptive immunity. Immunol Res 33 : 83 101.
21. Jenkins C Chart H (1999) Serodiagnosis of infection with verocytotoxin-producing Escherichia coli. J Appl Microbiol 86 : 569 575.
22. Johnson RP, Cray WC Jr. Johnson ST (1996) Serum antibody responses of cattle following experimental infection with Escherichia coli O157:H7. Infect Immun 64 : 1879 1883.
23. Kagnoff MF (2006) Microbial-epithelial cell crosstalk during inflammation: the host response. Ann NY Acad Sci 1072 : 313 320.
24. Kenny B Finlay BB (1995) Protein secretion by enteropathogenic Escherichia coli is essential for transducing signals to epithelial cells. Proc Natl Acad Sci USA 92 : 7991 7995.
25. Kudva IT, Krastins B, Sheng H, Griffin RW, Sarracino DA, Tarr PI, Hovde CJ, Calderwood SB John M (2006) Proteomics-based expression library screening (PELS): a novel method for rapidly defining microbial immunoproteomes. Mol Cell Proteomics 5 : 1514 1519.
26. Laegreid WW, Elder RO Keen JE (1999) Prevalence of Escherichia coli O157:H7 in range beef calves at weaning. Epidemiol Infect 123 : 291 298.
27. Li Y, Frey E, Mackenzie AM Finlay BB (2000) Human response to Escherichia coli O157:H7 infection: antibodies to secreted virulence factors. Infect Immun 68 : 5090 5095.
28. Lissner R, Schmidit H Karch H (1996) A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC-hemolysin of Escherichia coli O157:H7. Infection 24 : 378 383.
29. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, Fort M Hershberg RM (2004) Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 113 : 1296 1306.
30. Low JC, McKendrick IJ, McKechnie C, Fenlon D, Naylor SW, Currie C, Smith DG, Allison L Gally DL (2005) Rectal carriage of enterohemorrhagic Escherichia coli O157 in slaughtered cattle. Appl Environ Microbiol 71 : 93 97.
31. Madden RD, Sauer JR Dillwith JW (2002) A proteomics approach to characterizing tick salivary secretions. Exp Appl Acarol 28 : 77 87.
32. Matsunaga T Rahman A (1998) What brought the adaptive immune system to vertebrates? - The jaw hypothesis and the seahorse. Immunol Rev 166 : 177 186.
33. Naylor SW, Low JC, Besser TE, Mahajan A, Gunn GJ, Pearce MC, McKendrick IJ, Smith DG Gally DL (2003) Lymphoid follicle-dense mucosa at the terminal rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in the bovine host. Infect Immun 71 : 1505 1512.
34. Naylor SW, Roe AJ, Nart P, Spears K, Smith DG, Low JC Gally DL (2005) Escherichia coli O157:H7 forms attaching and effacing lesions at the terminal rectum of cattle and colonization requires the LEE4 operon. Microbiology 151 : 2773 2781.
35. Parsot C (2005) Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors. FEMS Microbiol Lett 252 : 11 18.
36. Pirro F, Wieler LH, Failing K, Bauerfeind R Baljer G (1995) Neutralizing antibodies against Shiga-like toxins from Escherichia coli in colostra and sera of cattle. Vet Microbiol 43 : 131 141.
37. Potter AA, Klashinsky S, Li Y et al 2004) Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine 22 : 362 369.
38. Poxton IR (1995) Antibodies to lipopolysaccharide. J Immunol Methods 186 : 1 15.
39. Pruimboom-Brees IM, Morgan TW, Ackermann MR, Nystrom ED, Samuel JE, Cornick NA Moon HW (2000) Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins. Proc Natl Acad Sci USA 97 : 10325 10329.
40. Razzaq S (2006) Hemolytic uremic syndrome: an emerging health risk. Am Fam Physician 74 : 991 996.
41. Rezaei N (2006) Therapeutic targeting of pattern-recognition receptors. Int Immunopharmacol 6 : 863 869.
42. Roe AJ, Naylor SW, Spears KJ et al 2004) Co-ordinate single-cell expression of LEE4- and LEE5-encoded proteins of Escherichia coli O157:H7. Mol Microbiol 54 : 337 352.
43. Rollins SM, Peppercorn A, Hang L, Hillman JD, Calderwood SB, Handfield M Ryan ET (2005) In vivo induced antigen technology (IVIAT). Cell Microbiol 7 : 1 9.
44. Rumbo M, Nempont C, Kraehenbuhl JP Sirard JC (2006) Mucosal interplay among commensal and pathogenic bacteria: lessons from flagellin and Toll-like receptor 5. FEBS Lett 580 : 2976 2984.
45. Secundino I, Lopez-Macias C, Cervantes-Barragan L et al 2006) Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response. Immunology 117 : 59 70.
46. Sheng H, Lim JY, Knecht HJ, Li J Hovde CJ (2006) Role of Escherichia coli O157:H7 virulence factors in colonization at the bovine terminal rectal mucosa. Infect Immun 74 : 4685 4693.
47. Sherman P, Soni R Yeger H (1988) Characterization of flagella purified from enterohemorrhagic, vero-cytotoxin-producing Escherichia coli serotype O157:H7. J Clin Microbiol 26 : 1367 1372.
48. Sitaraman SV, Klapproth JM, Moore DA III., Landers C, Targan S, Williams IR Gewirtz AT (2005) Elevated flagellin-specific immunoglobulins in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 288 : G403 G406.
49. Spivak J, Landers CJ, Vasiliauskas EA, Abreu MT, Dubinsky MC, Papadakis KA, Ippoliti A, Targan SR Fleshner PR (2006) Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease. Inflamm Bowel Dis 12 : 1122 1130.
50. Stenutz R, Weintraub A Widmalm G (2006) The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol Rev 30 : 382 403.
51. Trent MS, Stead CM, Tran AX Hankins JV (2006) Diversity of endotoxin and its impact on pathogenesis. J Endotoxin Res 12 : 205 223.
52. Van Donkersgoed J, Hancock D, Rogan D Potter AA (2005) Escherichia coli O157:H7 vaccine field trial in 9 feedlots in Alberta and Saskatchewan. Can Vet J 46 : 724 728.
53. Westerman RB, He Y, Keen JE, Littledike ET Kwang J (1997) Production and characterization of monoclonal antibodies specific for the lipopolysaccharide of Escherichia coli O157. J Clin Microbiol 35 : 679 684.
54. Widiasih DA, Matsuda I, Omoe K, Hu DL, Sugii S Shinagawa K (2004) Passive transfer of antibodies to Shiga toxin-producing Escherichia coli O26, O111 and O157 antigens in neonatal calves by feeding colostrum. J Vet Med Sci 66 : 213 215.
55. Wray C, McLaren IM, Randall LP Pearson GR (2000) Natural and experimental infection of normal cattle with Escherichia coli O157. Vet Rec 147 : 65 68.
56. Yang SK, Eckmann L, Panja A Kagnoff MF (1997) Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 113 : 1214 1223.
57. Yokomizo Y, Watanabe F, Imada Y, Inumaru S, Yanaka T Tsuji T (2002) Mucosal immunoadjuvant activity of the low toxic recombinant Escherichia coli heat-labile enterotoxin produced by Bacillus brevis for the bacterial subunit or component vaccine in pigs and cattle. Vet Immunol Immunopathol 87 : 291 300.